Wednesday, July 8, 2026
🇺🇸 FDA

pharma · Cystic Fibrosis · Rheumatoid Arthritis · LKFT

Lakefront Biotherapeutics NV

Lakefront Biotherapeutics NV trial registry — 131 ClinicalTrials.gov studies with program phase, status, and indication context.

Website Investor relations
Yalelaan 60, 5th floor, Utrecht 3584 CM, NL HQ
2016 Founded
9 Employees
Public company Type
LKFT · NYSE Ticker
Company details
Status
Public
HQ
Yalelaan 60, 5th floor, Utrecht 3584 CM, NL
Founded
2016
Employees
9
Programs
99
Drugs
26
Patents
0
Official website ↗ All projects Drug pipeline News & analysis
Intelligence · Clinical Trials

Lakefront Biotherapeutics NV clinical trials

Registry index of 131 ClinicalTrials.gov studies linked to Lakefront Biotherapeutics NV programs — each row shows trial ID, program name, phase, status, and indication.

Lakefront Biotherapeutics NV trial registry — 131 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

8 updates

Latest clinical program signals indexed for Lakefront Biotherapeutics NV.

  1. PEG-liposomal prednisolone sodium phosphate — Phase 2

    Clinical update

  2. GLPG3970 film-coated tablet — Phase 1

    Clinical update

  3. GLPG CAR T-cell therapy — Phase 3

    Clinical update

  4. Atorvastatin — Phase 1

    Clinical update

  5. 500 mg GLPG1837 as oral suspension — Phase 1

    Clinical update

  6. 200 mg GLPG0634 as capsules, fasted — Phase 1

    Clinical update

  7. 100 mg dose of [14C] GLPG0634 — Phase 1

    Clinical update

  8. MOR 106 — Phase 2

    Clinical update

Trial registry

131 studies

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.